www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
STRENGTHS AND LIMITATIONS OF THIS STUDY This long-term follow-up of a randomised controlled trial with blinded outcome assessment helps fill the evidence gap…
STRENGTHS AND LIMITATIONS OF THIS STUDY This long-term follow-up of a randomised controlled trial with blinded outcome assessment helps fill the evidence gap…
➡️ Continued on ES/IODE
➡️ Continued on ES/IODE
"Therefore, activation of Panx1/P2X7 purinoceptors appears to play a significant role in the neuroprotective mechanism of IPC."
"Therefore, activation of Panx1/P2X7 purinoceptors appears to play a significant role in the neuroprotective mechanism of IPC."
"IPC-induced neuroprotective effects were significantly abolished by pretreatment of mefloquine (15.0 mg/kg orally; 30.0 mg/kg orally), blocker of Panx1/P2X7 purinoceptor."
"IPC-induced neuroprotective effects were significantly abolished by pretreatment of mefloquine (15.0 mg/kg orally; 30.0 mg/kg orally), blocker of Panx1/P2X7 purinoceptor."
中国単施設、脳梗塞への血栓回収に成功した60例をランダム化——
・(元)閉塞部「2分バルーン拡張⇨2分再疎通」×4サイクルで対照
に比べ、48時間後の梗塞巣増大を有意に抑制。
・一方、90日後mRSには群間差なし。
抄録🔗 x.gd/RHKPx
中国単施設、脳梗塞への血栓回収に成功した60例をランダム化——
・(元)閉塞部「2分バルーン拡張⇨2分再疎通」×4サイクルで対照
に比べ、48時間後の梗塞巣増大を有意に抑制。
・一方、90日後mRSには群間差なし。
抄録🔗 x.gd/RHKPx